Pediatric T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma therapy


Published: June 11, 2009
Abstract Views: 282
PDF: 270
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in childhood are recognized to be two different pathologies with different biological basis and are treated according to different pediatric protocols. Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. Although it may affect children of any age, there is a peak modal distribution between 3 and 6 years.

Supporting Agencies


Pession, A., Masetti, R., & Rondelli, R. (2009). Pediatric T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma therapy. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.548

Downloads

Citations